Scientists in the lab of Marian Walhout, PhD, have applied a powerful tool in a new way to characterize genetic variants associated with human disease that will allow researchers to more easily and efficiently describe genomic variations underlying complex, multi-gene diseases.
Mitchell Sokoloff, MD, discusses the controversy surrounding prostate-specific antigen (PSA)-based screening recommendations in this Expert’s Corner video.
In a promising breakthrough for smokers who are trying to quit, neuroscientists at UMass Medical School and The Scripps Research Institute have identified novel circuitry in the brain responsible for anxiety commonly experienced during withdrawal from nicotine addiction.
Youth nicotine addiction expert Joseph DiFranza comments on the latest report from the Centers for Disease Control’s National Youth Tobacco Survey that e-cigarette use among middle and high school students tripled from 2013 to 2014.
Peter Chai, MD, fellow in medical toxicology at UMMS, explains the benefits of using Google Glass in an emergency room in an April 17 Telegram & Gazette story.
An advanced smartphone application developed at Worcester Polytechnic Institute to help people with diabetes better manage their weight and blood sugar level and assess the status of chronic foot ulcers, is entering a pilot clinical study at UMass Medical School.
Researchers from the UMass Center for Microbiome Research participated in a Twitter chat Thursday, April 9, to answers questions related to the microbiome and health.
UMass Medical School researchers are using CRISPR/Cas9, a powerful gene editing tool, to develop a novel technology that can potentially cut the DNA of the latent HIV virus out of an infected cell.
Vanni Bucci, PhD, from UMass Dartmouth, is collaborating with colleagues in the UMass Center for Microbiome Research to sequence the intestinal microbiome with the goal of targeting treatments for specific enteric diseases and prototyping probiotic cocktails that could be used as a substitute for antibiotic treatment.
Based on the success of the Inflammatory Bowel Disease Anti-Inflammatory Diet, Barbara Olendzki is collaborating with colleagues in the UMass Center for Microbiome Research to uncover how exactly this diet affects gut bacteria.